Collagen-Biostimulating Volume · PDLLA + HA

JUVELOOK Volume Treatment in Seoul

JUVELOOK Volume (sold internationally as LENISNA) is a PDLLA + HA collagen-biostimulating injectable for facial volume loss — cheeks, mid-face, and nasolabial folds. It carries roughly 4× the PDLLA dose of base JUVELOOK for deeper volumization, pairing same-day HA support with gradual collagen build over months. It is MFDS-approved in Korea and CE-marked, but NOT FDA-approved. A dermatologist consultation confirms suitability, and individual results vary.

皮膚科専門医

Board-Certified

AAD International Fellow

IFAAD

FDA 認可機器

該当施術

MFDS 登録

韓国保健福祉部

ユン・サンヨル院長監修

皮膚科専門医 · 院長 · AAD会員

概要

JUVELOOK Volume in Seoul — PDLLA + HA collagen-biostimulating injectable for cheek hollowing, mid-face volume loss, and nasolabial folds. MFDS-approved, not FDA-approved.

こんなお悩みの方へ

Cheek hollowing and mid-face volume loss
Nasolabial folds and soft facial contour
Tired, flat, or aged appearance from deflation
Patients preferring gradual, natural volume over immediate filler

推奨される方

Patients with mild-to-moderate facial volume loss wanting a natural, gradual change
Those preferring collagen-biostimulating volume over immediate HA filler
Patients ready for a 2-3 session course at about 1-month intervals
Patients wanting honest regulatory disclosure (MFDS / CE, not FDA)

所要時間: 20-40 min
推奨回数: 2-3 at about 1-month intervals
ダウンタイム: Minor (resolves in a few days)
ピーク効果: 3-6 months (collagen remodeling)

効果の経過

Same day
Mild swelling, redness, tenderness, or small injection marks. Early volume/hydration effect is not the final result.
Days 1-7
Swelling or bruising gradually improves; the area may feel slightly firm or uneven temporarily.
Weeks 4-8
Collagen stimulation becomes more noticeable — subtle firmness, texture, and soft volume support.
Months 3-6
Gradual collagen change becomes more visible; facial volume and elasticity look more naturally improved.
Months 12-24
Maintenance timing varies; a follow-up session may be considered per skin condition and goals.

使用機器

JUVELOOK Volume PDLLA + HA collagen biostimulator

JUVELOOK Volume (VAIM PDLLA + HA, intl. LENISNA)

VAIM Co., Ltd. (Korea)MFDS-approved (Korea), CE-marked (EU). NOT FDA-approved.

主要仕様

Active: PDLLA microspheres + HA carrier (about 4× PDLLA dose of base JUVELOOK)
Mechanism: HA same-day support + PDLLA collagen build over months
Placement: deep dermis or subcutaneous, per treatment area
Course: 2-3 sessions at about 1-month intervals
: Cannula for periorbital and other high-risk zones
: Restoration effect typically observed from around 6 weeks

施術の流れ

01
Dermatologist evaluates facial structure, skin quality, volume loss, and goals — confirming suitability or a better route
02
Areas are mapped around facial balance (cheeks, mid-face, nasolabial folds), not simply adding volume
03
After cleansing, JUVELOOK Volume is injected in the deep dermis or subcutaneous layer per area
04
Session takes about 20-40 minutes; guidance on swelling and follow-up timing is provided
05
A 2-3 session course at about 1-month intervals is typical, adjusted to response

“注射薬とエネルギー機器は必ず医師が直接行い、看護師や技術者に委ねることはありません。当院の診療は皮膚科専門医が主導いたします。”
— ユン・サンヨル院長 · 診療院長 · 皮膚科専門医 · AAD International Fellow

アフターケア

First 24 hours
Avoid touching, pressing, or rubbing the area. Skip heavy exercise, alcohol, sauna, hot baths, and strong heat. Mild swelling or tenderness may occur.
Days 1-3
Bruising or swelling may become more noticeable before improving. Gentle skincare and sunscreen. Contact the clinic for severe pain or unusual discoloration.
Week 1
Most temporary injection-related reactions improve within several days. Do not massage the area unless your dermatologist instructs it.
Long-term
Maintain sunscreen and a gentle routine. Collagen results are gradual — assess over time. Follow-up sessions may be recommended per your plan.

よくあるご質問

Is JUVELOOK Volume the same as a filler, or FDA-approved?

It differs from a traditional HA filler. While HA fillers mainly create immediate volume by filling space, JUVELOOK Volume combines HA with PDLLA to support gradual collagen stimulation, so the final result develops more slowly and naturally. Regulatory status: it is MFDS-approved in Korea and CE-marked, but NOT FDA-approved as an injectable in the US.

How is JUVELOOK Volume different from base JUVELOOK?

Same active ingredients (PDLLA + HA), different formulation. Base JUVELOOK uses smaller particles for superficial-to-mid-dermal skin boosting (texture, fine lines). JUVELOOK Volume — sold internationally as LENISNA — has roughly 4× higher PDLLA dose and a thicker HA carrier for deep-dermal or subcutaneous volumization of the mid-face, cheeks, and folds.

When will I see results, and how many sessions are needed?

Some early change may show soon from the HA component, but collagen-related improvement develops gradually — often noticeable around 4-8 weeks, with more visible change around 3-6 months. Many patients are advised 2-3 sessions at about 1-month intervals; the ideal number depends on volume loss, treatment area, and goals, set after consultation.

What are the most serious risks?

Rare but serious: vascular occlusion (including visual complications) from inadvertent intravascular injection, particularly in glabellar, periorbital, and forehead zones. The Asia-Pacific PDLLA-HA vascular-safety consensus guides safe technique — cannula for high-risk zones, hyaluronidase emergency kit, and anatomy-based depth control. Common transient risks include swelling, bruising, and mild redness; rare late-onset nodules have been documented and are manageable.

注意・禁忌事項

以下に該当される場合は、診察時に必ず担当医にお伝えください。治療をお受けいただけない場合や、計画を調整させていただく場合がございます。

施術前のカウンセリングで禁忌事項を詳しくご案内します。

ご来院にあたって

Mild swelling or bruising usually resolves within a few days; bruising can take longer in some patients
Full course is about 2-3 sessions at 1-month intervals — short-trip patients complete one session and continue later
Avoid heat and exercise 24-48h; collagen-driven change develops over 3-6 months after departure

参考文献

本ページに記載された医学的情報（機器仕様・施術効果・安全性等）は、以下の一次資料に基づいて作成されています。各記載は対応する文献を参照しています。3 refs

[1]Hybrid PDLLA-HA for Tear Trough Rejuvenation. Aesthetic Plast Surg (Young & Lau) — prospective PDLLA-HA study N=15 (2026).
[2]Safe Injection Technique for PDLLA-HA200 (Visual Impairment Consensus). J Craniofac Surg (Lau et al.) — authoritative PDLLA-HA vascular-safety consensus (2025).
[3]PLLA vs PDLLA Fillers: Comparative Mouse Study. In Vivo (Jang et al.) — independent SNU/Sookmyung PLLA vs PDLLA comparator (2026).